investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Identifying Microbial Metabolites and the Bacteria Responsible for their Formation

Wendy Russell

0 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Emerging evidence suggests that the gut microbiota play an important role in the development of many diseases including diabetes, cardiovascular disease and cancer. Despite tremendous advances in characterizing microbial diversity within the gastrointestinal tract, very little is known about their function and role of even the most dominant bacterial species within the human host. It is becoming widely accepted that the metabolic products formed by gut bacteria directly impact on human health and disease, particularly regarding immune response and inflammation. In most cases, the products of metabolism are uncharacterized and their mechanism of action unknown. To advance this area of research, this information is vital. This proposal will establish the link between microbial diversity and metabolic functionality by 1) identifying the microbial metabolites and their in vivo conCentreations, 2) establishing their mechanism of formation and 3) characterizing the bacterial species responsible. It will deliver these results through a series of acute human interventions with well characterized substrates (macro-, micro- and non-nutrients quantitatively determined) and both the microbial population and metabolites produced identified. The mechanism of transformation and the bacteria responsible will be determined by in vitro incubations, again with well characterized substrates, key metabolites and a unique and comprehensive collection of microbial isolates. Finally, the inflammatory activity of the quantitatively identified metabolites will be established ex vivo. This investigation will deliver several important outcomes including: Identifying microbial metabolites which exhibit inflammatory activity at relevant in vivo conCentreations. This will provide essential information (not currently available) informing wider studies looking at the action of microbial metabolites on particular receptors and biomarkers of health. Determining the bacterial species responsible, elucidating their potential function in the gut. Identification of keystone species with unique function will be a major focus and will allow us to identify extent of redundancy of certain species with regard to metabolite production. Established is the role of major macronutrients to drive microbial metabolism, both in the production of phytochemical metabolites and provision of carbohydrate/protein by-products. Only once the complex interplay between diet, the gut microbiota and human health is firmly established, will the role by which the gut microbiota contributes to maintenance of health or disease development be elucidated.

Related projects